These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 26934885)

  • 1. Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities.
    Bailey JR; Aggarwal A; Imperiale TF
    Gut Liver; 2016 Mar; 10(2):204-11. PubMed ID: 26934885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stool Testing for Colorectal Cancer Screening.
    Robertson DJ; Imperiale TF
    Gastroenterology; 2015 Oct; 149(5):1286-93. PubMed ID: 26033632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.
    Iannone A; Losurdo G; Pricci M; Girardi B; Massaro A; Principi M; Barone M; Ierardi E; Di Leo A
    J Gastrointest Cancer; 2016 Jun; 47(2):143-51. PubMed ID: 26922358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel multitarget stool DNA test for colorectal cancer screening.
    Malik P
    Postgrad Med; 2016; 128(2):268-72. PubMed ID: 26753807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
    N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Target Stool DNA Test: Is the Future Here?
    Sweetser S; Ahlquist DA
    Curr Gastroenterol Rep; 2016 Jun; 18(6):30. PubMed ID: 27165404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance improvements of stool-based screening tests.
    van Dam L; Kuipers EJ; van Leerdam ME
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):479-92. PubMed ID: 20833351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Clinician's Guide to Fecal Occult Blood Testing for Colorectal Cancer.
    Bechtold ML; Ashraf I; Nguyen DL
    South Med J; 2016 Apr; 109(4):248-55. PubMed ID: 27043809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
    Berger BM; Schroy PC; Dinh TA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive screening tests for colorectal cancer.
    Imperiale TF
    Dig Dis; 2012; 30 Suppl 2():16-26. PubMed ID: 23207928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-target stool DNA test: a new high bar for noninvasive screening.
    Ahlquist DA
    Dig Dis Sci; 2015 Mar; 60(3):623-33. PubMed ID: 25492503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular markers for colorectal cancer screening.
    Dickinson BT; Kisiel J; Ahlquist DA; Grady WM
    Gut; 2015 Sep; 64(9):1485-94. PubMed ID: 25994221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stool DNA methylation assays in colorectal cancer screening.
    Kadiyska T; Nossikoff A
    World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing.
    Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L
    Dig Dis Sci; 2018 Jun; 63(6):1449-1453. PubMed ID: 29516325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
    Berger BM; Ahlquist DA
    Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue.
    Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM
    Dig Dis Sci; 2017 Mar; 62(3):678-688. PubMed ID: 28044229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection.
    Pickhardt PJ
    Abdom Radiol (NY); 2016 Aug; 41(8):1441-4. PubMed ID: 27259335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
    Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Necessity and feasibility of screening for colorectal cancer in China].
    Zhang SZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.